Cargando…
Creating dermatology guidelines for COVID-19: The pitfalls of applying evidence-based medicine to an emerging infectious disease
Autores principales: | Freeman, Esther E., McMahon, Devon E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194997/ https://www.ncbi.nlm.nih.gov/pubmed/32278795 http://dx.doi.org/10.1016/j.jaad.2020.04.002 |
Ejemplares similares
-
COVID-19 and Dermatology: One Year in Review
por: Freeman, Esther E., et al.
Publicado: (2021) -
Response to: “Comment on ‘The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries’”
por: Freeman, Esther E., et al.
Publicado: (2021) -
The American Academy of Dermatology COVID-19 registry: Crowdsourcing dermatology in the age of COVID-19
por: Freeman, Esther E., et al.
Publicado: (2020) -
Timing of PCR and antibody testing in patients with COVID-19–associated dermatologic manifestations
por: Freeman, Esther E., et al.
Publicado: (2021) -
Skin reactions to COVID-19 vaccines: An American Academy of Dermatology/International League of Dermatological Societies registry update on reaction location and COVID vaccine type
por: Freeman, Esther E., et al.
Publicado: (2022)